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lucokinase (GK) activity plays a key role in glucose-
stimulated insulin secretion from pancreatic 
 
 
 
 cells.
Insulin regulates GK activity by modulating its asso-
ciation with secretory granules, although little is known
about the mechanisms involved in regulating this association.
Using quantitative imaging of multicolor ﬂuorescent proteins
fused to GK, we found that the dynamic association of GK
with secretory granules is modulated through nitric oxide
(NO). Our results in cultured 
 
 
 
 cells show that insulin stim-
ulates NO production and leads to S-nitrosylation of GK.
Furthermore, inhibition of NO synthase (NOS) activity
blocks insulin-stimulated changes in both GK association
G
 
with secretory granules and GK conformation. Mutation of
cysteine 371 to serine blocks S-nitrosylation of GK and
causes GK to remain tightly bound to secretory granules.
GK was also found to interact stably with neuronal NOS
as detected by coimmunoprecipitation and ﬂuorescence
resonance energy transfer. Finally, attachment of a nuclear
localization signal sequence to NOS drives GK to the nucleus
in addition to its normal cytoplasmic and granule targeting.
Together, these data suggest that the regulation of GK local-
ization and activity in pancreatic 
 
 
 
 cells is directly related
to NO production and that the association of GK with
secretory granules occurs through its interaction with NOS.
 
Introduction
 
Glucokinase (GK)* activity is a major determinant of 
 
 
 
 cell
glucose metabolism and insulin secretion (Sweet et al., 1996;
Matschinsky et al., 1998; Matschinsky, 2002). Thus, a com-
plete model of its regulation is central to our understanding of
glucose homeostasis and the pathogenesis of diabetic disease
states. To maintain physiological glucose responsiveness,
GK activity needs to be constrained within a very narrow
range (Wang and Iynedjian, 1997; Matschinsky et al.,
1998). Regulation of GK expression in 
 
 
 
 cells has been
widely studied and is induced mainly by glucose, although
it can be modulated by other factors, including insulin
(Leibiger et al., 2001; Matschinsky, 2002). Posttranslational
regulation of GK has only more recently been described, and
the mechanisms involved in this mode of regulation are not
well known. Recent studies have shown that low levels of
glucose cause an association of GK with secretory granules
(Toyoda et al., 1999; Stubbs et al., 2000; Rizzo et al., 2002)
and that this association correlates with a decrease in GK
activity (Rizzo et al., 2002). Prolonged exposure to high glucose
(
 
 
 
20 min) causes dissociation of GK from the granule along
with conformational changes associated with activation.
Glucose-stimulated GK regulation is blocked by inhibitors
of insulin secretion, and insulin by itself can rapidly (
 
 
 
2
min) induce similar changes to GK localization and activity
(Rizzo et al., 2002). This suggests that minute-to-minute
regulation of GK activity and localization occurs through
receptor-mediated signaling and not by interaction between
glucose and GK.
The molecular mechanism of GK association with secretory
 
granules and the processes that modulate this association
are unknown. To address the mechanism of GK association
with secretory granules, we examined the role of nitric oxide
synthase in this regulation. Neuronal nitric oxide synthase
(nNOS) is activated by a rise in intracellular calcium,
 
which is a known response of 
 
 
 
 cells to glucose or insulin
stimulation (Aspinwall et al., 2000); and nNOS is also
known to be localized on insulin secretory granules (Lajoix
et al., 2001). Nitric oxide (NO) has also been shown to
have a stimulatory affect on glucose-stimulated insulin secre-
tion from both cultured 
 
 
 
 cell lines and pancreatic islets
(Smukler et al., 2002; Kaneko et al., 2003). However, these
findings are highly controversial, and an inhibitory effect
on insulin secretion has also been shown using a variety of
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experimental approaches. (Salehi et al., 1996; Lajoix et al.,
2001; Henningsson et al., 2002). This controversy points to
the need for more careful consideration of potential targets
for NO in the regulation of glucose-stimulated insulin se-
cretion in order to understand the role of NO synthase
(NOS) in 
 
 
 
 cell function. GK is one potential target for
regulation by NO, since GK contains several cysteines that
have been shown to be critical for maintaining catalytic ac-
tivity (Tiedge et al., 2000).
 
Results and discussion
 
To assess the role of NOS in the regulation of GK by insu-
lin, we examined whether insulin could stimulate NO
production in 
 
 
 
 cells. 
 
 
 
TC3 cells were loaded with
4-amino-5-methylamino-2
 
 
 
,7
 
 
 
-difluorofluorescein diacetate
(DAF-FM) (Kojima et al., 1999), an indicator dye whose
fluorescence increases upon reaction with NO. A rapid in-
crease in the fluorescence of DAF-FM was observed within
minutes in insulin-treated cells compared with untreated
cells (Fig. 1 A). This indicates that insulin treatment results
in NO production on a time scale consistent with regula-
tion of GK (Rizzo et al., 2002). We also examined the role
of NOS activation in the regulation of GK association with
secretory granules. Association of GK with secretory gran-
ules was analyzed in cells expressing a YFP-labeled GK
(GK-YFP) and a CFP targeted to insulin granules by inser-
tion into a proinsulin cDNA (Rizzo et al., 2002; Watkins
et al., 2002) (Fig. 1 B). Association of GK-YFP with CFP-
labeled granules can be assayed by selectively photobleach-
ing the GK-YFP in a small region of the cell (Fig. 1 B,
white box) and monitoring the FRAP to the CFP-labeled
granules. Recovery of GK-YFP to CFP-labeled granules oc-
curs at a faster rate in insulin-treated cells (Fig. 1 C), which
indicates a net translocation of GK to the cytoplasm (Rizzo
et al., 2002). A significant difference in the degree of fluo-
rescence recovery between insulin-treated (5 min, 100 nM)
and untreated cells could be reliably measured 2 s into re-
covery (Fig. 1 D). Inhibition of NOS activity using N
 
G
 
-
nitro-
 
L
 
-arginine-methyl ester (L-NAME) blocked the stim-
ulatory effects of insulin on GK-YFP FRAP, indicating a
requirement for NO production. Furthermore, the effects
of NOS inhibition were reversed by treatment with SNAP,
an NO releasing agent. These results are consistent with a
requirement for NO production in modulating GK associ-
ation with secretory granules.
The requirement for NO production in GK regulation
was also tested using a fluorescence resonance energy trans-
fer (FRET)–based assay to examine changes in GK confor-
mation. The FRET ratio between CFP and YFP inserted on
opposing ends of GK decreases in cells treated with insulin
(Fig. 1 E) and correlates with increased GK activity (Rizzo et
al., 2002). Treatment with L-NAME prevented the decrease
in the FRET ratio observed with insulin treatment alone. A
decrease in the FRET ratio was observed in cells treated with
an NO releasing agent either in the presence of L-NAME
and insulin or in the absence of other treatments. These re-
sults suggest that NO production is a regulator of GK and
mediates the effects of insulin treatment. Glucose-stimulated
activation of GK FRAP and FRET was also sensitive to
treatment with L-NAME (unpublished data) and is consis-
tent with the effect of glucose-stimulated insulin secretion
on autofeedback regulation of GK (Rizzo et al., 2002).
Figure 1. Regulation of GK by insulin requires NO. (A)  TC3 cells 
were starved for 4 h before loading with DAF-FM and analysis using 
confocal microscopy. The change in DAF intensity is represented as 
the change in fluorescence/initial fluorescence (dF/F0) from the 
average of at least 10 cells treated with 100 nM insulin (indicated by 
the arrow,  ) or left untreated ( ). (B) FRAP measurements were 
taken in cells expressing GK-YFP (yellow) and proinsulin-CFP (cyan) 
by selectively photobleaching YFP fluorescence in a small region 
(white box) of the cell containing several granules. (C) Fluorescence 
recovery of GK-YFP to CFP-labeled insulin granules was measured 
after photobleaching GK-YFP in starved cells ( ) and after insulin 
treatment (100 nM, 5 min,  ). The bleaching period is indicated 
by the arrow and broken lines. (D) FRAP measurements show 
fluorescence intensity of granule-associated GK-YFP immediately 
after photobleaching (white bars) and 2 s after photobleaching (black 
bars) and expressed as the percentage of prebleached fluorescence 
intensity. Cells were starved previously in BMHH for 3 h before 
insulin treatment (5 min), pretreatment with L-NAME (5 mM, 10 min) 
before insulin treatment (100 nM, 5 min), and after treatment with 
SNAP (100  M, 1 min). Statistical significance from initial postbleach 
intensity (P   0.05, t test) is denoted by an asterisk. (E) Cells 
expressing CFP-GK-YFP were examined for FRET by fluorescence 
microscopy as indicated. Statistical significance (P   0.05 by ANOVA 
or t test as appropriate) is denoted by an asterisk. Cells were treated 
under the same conditions as in D. (F) Nitrosylated proteins 
were precipitated with neutravidin-agarose after biotinylation of 
S-nitrosylated proteins from cell lysates. Cells were treated as 
above where indicated. GK was detected in unreacted lysates and 
precipitated fractions by Western blot using an antibody to GK 
(Jetton and Magnuson, 1992).T
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To determine whether regulation of GK by NO is the re-
sult of direct posttranslational modification of GK, we ex-
amined whether GK was S-nitrosylated in insulin-treated
cells. Nitrosylated proteins from cell lysates were chemically
modified with biotin (Jaffrey et al., 2001) before isolation
using neutravidin-agarose and analysis by Western blot. Ni-
trosylated GK was detected only in precipitates from insu-
lin-treated cells but not from untreated cells or cells treated
with L-NAME in addition to insulin (Fig. 1 F). Together
with our fluorescence-based assays, these results support a
model in which changes in GK localization and activity are
related to S-nitrosylation of GK.
To test the role of S-nitrosylation in regulating GK, we
examined whether site-directed mutagenesis of GK could
block its nitrosylation and affect its regulation. Since reac-
tion of NO with cysteines can be greatly enhanced by a
consensus nitrosylation motif (Stamler et al., 1997), we ex-
amined the primary structure of GK for potential nitrosyla-
tion sites. Four such consensus sites were found in GK
(C220, C364, C371, and C434), and each was subse-
quently mutated to serine, an amino acid that does not re-
act with NO. The mutant GK constructs were tagged with
YFP, and the S-nitrosylation of the mutated proteins was
assessed (Fig. 2 A). Of the four mutations generated, only
C371S eliminated GK nitrosylation, although a slight de-
crease in the amount of nitrosylated GK was observed for
the C364S mutation. Furthermore, the C371S mutant
stopped insulin-stimulated FRAP to CFP-labeled granules
(Fig. 2 B) and changes in FRET (Fig. 2 C). Mutation of
C364S did not have a significant effect on insulin-stimu-
lated FRAP to CFP-labeled granules (Fig. 2 B) and changes
in FRET (Fig. 2 C), suggesting that nitrosylation of C364
is not critical to GK regulation. Thus, nitrosylation of cys-
teine 371 plays a key role in modulating GK association
with secretory granules and conformational changes that
correlate with GK activation.
To assess the role of C371 in regulating GK activity, the
kinetic parameters of recombinantly expressed and purified
GK(C371S) were examined and compared with the kinetic
parameters of native GK. GK-C371S was found to have an
increased K
 
m
 
 for glucose (12.5 
 
 
 
 2.5 mM) and a reduced
V
 
max
 
 (30.6 
 
 
 
 0.3 U/mg protein) compared with GK (K
 
m 
 
 
 
8.7 
 
 
 
 1.3 mM; V
 
max
 
 
 
 
 
 48.1 
 
 
 
 2.7 U/mg protein). Because
of the reducing agents needed to stabilize recombinantly ex-
pressed GK (Tippett and Neet, 1983; Tiedge et al., 1997;
Matschinsky et al., 1998), the effect of S-nitrosylation on
GK activity in vitro could not be determined. However, our
analysis of GK(C371S) is consistent with a previous analysis
(Tiedge et al., 2000) and shows that modification of C371
alters the enzymatic activity of GK.
Since other proteins that react with NO are known to
form complexes containing nNOS (Brenman et al., 1996;
Fang et al., 2000; Nedvetsky et al., 2002), we examined the
role of nNOS in determining GK localization. To detect in-
teraction between GK and nNOS, we immunoprecipitated
endogenous GK from cell lysates and probed for endoge-
nous nNOS by Western blot (Fig. 3 A). We were able to de-
tect nNOS in these precipitates and also from those of ex-
pressed GK-YFP and GK(C371S)-YFP. Incubation of GK
precipitates with diethylamine nitric oxide (DEANO), a
chemical that rapidly releases NO, resulted in elution of
nNOS from endogenous GK and GK-YFP precipitates but
not from GK(C371S)-YFP precipitates. These data show
that GK association with nNOS is both consistent with GK
association with secretory granules and also sensitive to the
presence of NO.
Interaction between nNOS and GK was also examined
in living cells by measuring changes in FRET between
CFP-labeled nNOS and GK-YFP. FRET between nNOS-
CFP and GK-YFP was verified by acceptor photobleaching
of either GK-YFP or GK(C371S)-YFP, which caused an
increase in nNOS-CFP fluorescence (Fig. 3 B). Insulin
treatment resulted in a decrease of the FRET between
nNOS-CFP and GK-YFP, whereas FRET between nNOS-
CFP and GK(C371S)-YFP increased (Fig. 3 C). The in-
crease in FRET between nNOS-CFP and nitrosylation-
resistant GK(C371S)-YFP is most likely due to dissociation
of competing endogenous GK and association of unbound
GK(C371S)-YFP to the vacated NOS binding sites. These
results indicate that GK and nNOS interact on secretory
granules either directly or as part of a complex. To deter-
Figure 2. Nitrosylation of cysteine 371 is required for GK regulation. 
(A) Mutant GK-YFP constructs were expressed in  TC3 cells. 
Nitrosylated proteins were biotinylated before immunoprecipitation 
of GK-YFP proteins and analysis by Western blot for GK (anti-GK) or 
biotinylated proteins using peroxidase-conjugated streptavidin 
(Strept-HRP). (B) Association of the GK-YFP mutants with secretory 
granules was measured using FRAP in cells expressing the indicated 
GK-YFP construct and proinsulin-CFP. Fluorescence intensity 
of granule-associated GK-YFP is expressed as the percentage of 
prebleached intensity immediately after bleaching (white bars) and 
2 s into recovery (black bars). Statistical significance from initial 
postbleach intensity (P   0.05, t test) is denoted by an asterisk. 
(C) Mutations were made in CFP-GK-YFP and expressed in  TC3 
cells. Cells were starved for 4 h in BMHH, and the normalized FRET 
ratio was calculated before (white bars) and after (black bars) 
stimulation with 100 nM insulin (5 min). Statistical significance from 
pretreatment FRET ratio (P   0.05, t test) is denoted by an asterisk.T
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mine whether the interaction between GK and nNOS
was sufficient to determine GK localization, we targeted
nNOS-CFP to the nucleus. A nuclear localization se-
quence from simian virus 40 large T antigen (Kalderon et
al., 1984; Lanford et al., 1986) was attached to the COOH
terminus of nNOS-CFP and coexpressed in 
 
 
 
 cells with
GK-YFP. GK-YFP localized to the nuclei of cells only
when coexpressed with the nucleus-targeted nNOS-CFP
(Fig. 3 D). Since the subcellular localization of GK can be
 
determined by the localization of nNOS, it suggests that
nNOS may be the primary target for GK on secretory
granules.
Overall, our data indicate that the GK localization and
activity in the 
 
 
 
 cell are determined by GK association
with nNOS and that association is disrupted by GK ni-
trosylation at cysteine 371. Regulation of GK-NOS as-
sociation by nitrosylation provides a sensitive means for
modulating GK activity, thus affecting glucose-stimulated
insulin secretion. Future work on the nature of the GK-
NOS association will certainly increase our understanding
of the signaling pathways that contribute to regulation of
glucose-stimulated insulin secretion. The regulation of GK
nitrosylation might also prove to be a useful target for
pharmacological manipulation in the treatment of diabetes
and other glycemic disorders. In addition, our data demon-
strate that changes in protein nitrosylation can regulate
protein localization, protein–protein interactions, and pro-
tein function in a highly specific and rapid way that is sim-
ilar to the role of protein phosphorylation.
 
Materials and methods
 
Cell culture
 
 
 
TC3 cells were cultured as described (Rizzo et al., 2002) and were trans-
ferred to media containing 1g/L glucose overnight before observation. 3 h
before experimentation, cells were washed four times and incubated with
BMHH buffer (125 mM NaCl, 5.7 mM KCl, 2.5 mM CaCl
 
2
 
, 1.2 mM MgCl
 
2
 
,
10 mM Hepes, pH 7.4) containing 0.1% BSA. For FRAP, CFP-GK-YFP
FRET, and nitrosylation experiments, DNA plasmids containing GK-YFP
constructs, proinsulin-CFP, or CFP-GK-YFP were introduced by electropo-
ration before seeding as described previously (Rizzo et al., 2002). For stud-
ies requiring cotransfection, plasmid DNA encoding the indicated con-
structs were transfected using either a ratio of (2 
 
 
 
g nNOS-CFP:1 
 
 
 
g
GK-YFP:6 
 
 
 
l FUGENE [Roche Applied Science]) or of (1 
 
 
 
g nNOS-CFP-
nuc:2 
 
 
 
g GK-YFP:6 
 
 
 
l FUGENE). Transfection was for 4 h in serum-free
media, followed by replacement with low-glucose media. Observation
took place the following day.
 
Generation of constructs
 
Mutations to GK-YFP were made by 4 primer PCR (with Advantage 2
Polymerase Mix; BD Biosciences, CLONTECH Laboratories, Inc.) using
the same set of end primers (sense, 5
 
 
 
-GGCACCAAAATCAACGGGAC-3
 
 
 
and
 
 
 
antisense, 5
 
 
 
-CTCGCCCTTGCTCACCAT-3
 
 
 
) along with primers con-
taining the mutation (C220S sense, 5
 
 
 
-GACCGCCAATCTGAGGTCG-3
 
 
 
and antisense, 5
 
 
 
-CGACCTCAGATTGGCGGTCT-3
 
 
 
; C364S sense, 5
 
 
 
-
CACCGACTCCGATATCGTGC-3
 
  
 
and
 
 
 
antisense, 5
 
 
 
-CACGATATCG-
GAGTCGGTGAC-3
 
 
 
; C371S sense, 5
 
 
 
-CCGTGCCTCTGAAAGCGTG-3
 
 
 
and antisense, 5
 
 
 
-CACGCTTTCAGAGGCACGGC-3
 
 
 
; C434S sense, 5
 
 
 
-
CACCCAACTCCGAAATCACCT-3
 
  
 
and antisense, 5
 
 
 
-GGTGATTTCG-
GAGTTGGGTG-3
 
 
 
). Mutated GK was then inserted into CFP-GK-YFP us-
ing restriction sites to replace wild-type GK. For bacterial expression, GK
and GK(C371S) were excised from GK-YFP plasmids using BglII and XmaI
and ligated into the BamHI and XmaI sites in pQE30 (QIAGEN). To cre-
ate nNOS-CFP constructs, a silent mutation was introduced into the
rat cDNA for nNOS in order to remove the AgeI restriction site using
the  QuickChange Site-Directed Mutagenesis Kit (Stratagene) (sense
primer, 5
 
 
 
-GGGATGACAACCGATACCACGAGGACATC-3
 
  
 
and
 
 
 
anti-
sense primer, 5
 
 
 
-GATGTCCTCGTGGTATCGGTTGTCATCCC-3
 
 
 
). The
cDNA for the modified rat nNOS was then amplified by PCR (sense, 5
 
 
 
-
AGCTAGCCACCATGGAAGAGAACACG-3
 
  
 
and antisense, 5
 
 
 
-TTAAC-
CGGTGAGCTGAAAACCTCATCTGC-3
 
 
 
) and inserted into the NheI and
AgeI restriction sites in the pECFP-nuc vector (BD Biosciences, CLON-
TECH Laboratories, Inc.), and a derivative vector with the nuclear local-
ization signal removed by BamHI and BglII digestion followed by religa-
tion. All primers were custom synthesized and purified by Integrated
DNA Technologies. All plasmid constructs were purified using DNA
preparation kits (QIAGEN), and the sequences of all constructs were veri-
fied by sequencing reactions performed by the Vanderbilt-Ingram Cancer
Center DNA Sequencing Shared Resource.
Figure 3. Association of GK with nNOS can direct GK 
localization. (A) Endogenous GK, GK-YFP, and C371S GK-YFP were 
immunoprecipitated from cell lysates using anti-GK antibodies or 
anti-GFP antibodies for YFP-tagged proteins in combination with 
agarose-conjugated secondary antibodies. Precipitates were then 
heated to 37 C for 10 min in the presence of 1 mM DEANO in PBS 
(lanes 3 and 4) or an equivalent volume of vehicle (DMSO) in PBS 
alone (lanes 1 and 2). Pellets (lanes 1 and 3) and supernatants (lanes 
2 and 4) were analyzed by SDS-PAGE and Western blot using anti-
nNOS antibodies. (B) Cells expressing nNOS-CFP and GK-YFP or 
GK(C371S)-YFP were examined by two-photon microscopy before 
and after photobleaching with a 514 nm Ar laser (indicated by the 
hatched region). Average relative fluorescence (n   6) for cellular 
CFP ( ) and YFP ( ) intensities were plotted versus time. A dotted 
line was drawn as a reference to indicate prebleach intensity. 
(C) FRET between nNOS-CFP and either GK-YFP ( ) or GK(C371S)-
YFP( ) was examined in living cells by two-photon microscopy. 
FRET ratios were normalized to pretreatment values (100%) before 
averaging (n   6) and plotted versus time. Addition of insulin 
(100 nM) is indicated by the arrow. (D) Cells were cotransfected 
with GK-YFP and nNOS-CFP-nuc and examined by confocal 
microscopy. In cells expressing both constructs, GK-YFP is found 
colocalized with nNOS in the nucleus (red arrows). GK-YFP did 
not localize to the nuclei of cells that were singly transfected with 
GK-YFP (white arrows). In the merged panel, the CFP image was 
colored blue and the YFP image was colored green. Colocalization 
is indicated by cyan (red arrows).T
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Microscopy
 
 
 
TC3 cells were labeled with 5 
 
 
 
M DAF-FM diacetate (Molecular Probes)
for 25 min at 25
 
 
 
C in BSA-free BMHH. Observation was with 488 nm exci-
tation and 505–530 nm collection by laser scanning confocal microscopy
(LSM510; Carl Zeiss MicroImaging, Inc.). During observation, cells were
heated to 32
 
 
 
C using a Bioptechs Delta T system. FRAP and intramolecular
FRET measurements were performed on cultured 
 
 
 
TC3 cells as described
previously (Rizzo et al., 2002). Statistical significance (P 
 
  
 
0.05 by
ANOVA or 
 
t
 
 test as appropriate) is denoted by an asterisk and was deter-
mined from at least three granules in the same region or at least three cells
for the FRET studies as compared with pretreatment FRET ratios. Data
shown is representative of at least three independent trials. Observation of
nNOS-CFP-nuc and GK-YFP were performed using the same filter settings
as the FRAP measurements. FRET between nNOS-CFP and GK-YFP was
observed using 864 nm two-photon excitation along with a KP700/514
main beam splitter and standard CFP and YFP collection using a 40
 
 
 
,
1.3NA F-FLUAR oil immersion objective lens. For the FRET measurements,
the temperature was maintained at 37
 
 C using an S-M incubator (Carl
Zeiss MicroImaging, Inc.) controlled by the CTI temperature regulator
along with humidification and an objective heater.
Detection of nitrosylated proteins
S-nitrosylated proteins were biotinylated and isolated from cell lysates us-
ing the protocol described (Jaffrey et al., 2001). Briefly, cells were lysed in
HEN buffer (250 mM Hepes, pH 7.7, 1 mM EDTA, 0.1 mM neocuproine)
using 0.5% Triton X-100 and 0.5% cholate before protection of free cys-
teines with methyl methanethiosulfonate (Pierce Chemical Co.) and de-
rivatization of S-nitrosylated cysteines with ascorbic acid and biotin-HPDP
(Pierce Chemical Co.). Biotinylated proteins were isolated by binding to
neutravidin-agarose (Pierce Chemical Co.) followed by five washes with a
high salt buffer (20 mM Hepes, pH 7.7, 600 mM NaCl, 1 mM EDTA, 0.5%
Triton X-100) and elution in HNE buffer (20 mM Hepes, pH 7.7, 100 mM
NaCl, 1 mM EDTA) plus 100 mM 2-mercaptoethanol. Alternatively, GK-
YFPs were isolated by immunoprecipitation with A.v. Peptide Antibody
(BD BioSciences, Clontech Laboratories, Inc.) preconjugated to IgG aga-
rose (Sigma-Aldrich). Western blots were then performed on eluted pro-
teins to detect GK and nitrosylated proteins.
Kinetic analysis of GK mutations
His-tagged recombinant GK and GK(C371S) were produced in M15
(pREP4) cells and purified by Ni:NTA affinity chromatography (QIAGEN)
precisely as described (Tiedge et al., 1997). Protein concentrations were
determined using the Advanced Protein Assay (Cytoskeleton Inc.) at A590
according to the manufacturer’s protocol. Kinetic analysis was performed
on 2 mU of purified protein at 37 C using a photometric assay containing
50 mM Hepes (pH 7.2), 100 mM KCl, 10 mM MgCl2, 2.5 mM dithiothrei-
tol, 5 mM ATP, 2 mM NAD , 4 U/ml glucose-6-phosphate dehydroge-
nase from Leuconostoc mesenteroides, and varying concentrations of glu-
cose. 1 U was defined as the amount of protein required to produce 1
 mole NADH per minute. NADH production was assayed from stopped
reactions (1 ml cold 500 mM NaHCO3 per 100  l reaction mix) as de-
scribed previously (Rizzo et al., 2002), and reaction velocities were calcu-
lated from reaction time courses over 2 min as a function of glucose con-
centration. Km and Vmax were calculated from linear regression analysis of
Hanes-Woolf plots using Prism software (Graphpad).
Immunoprecipitation
BMHH-starved cells from one 60-mm dish were collected in cold PBS, pH
7.4 (PBS, prepared from 10  solution [GIBCO BRL]), and resuspended in
lysis buffer (HNE buffer with 1% cholate, 1% Triton X-100, 1  Protease
Inhibitor Cocktail for use with Mammalian Cells and Tissue Extracts
[Sigma-Aldrich]) for 20 min. Following removal of insoluble material by
centrifugation (5 min, 3000 g), normalized amounts of protein (determined
by Advanced Protein Assay; A590) were incubated for 1 h with primary an-
tibodies for GK (Jetton and Magnuson, 1992) or GFP preconjugated to 25
 l agarose IgG in 750  l lysis buffer. Precipitates were washed twice in ly-
sis buffer and three times in HNE buffer before analysis by Western blot or
treatment with DEANO (Molecular Probes).
Figure preparation
Figures were prepared using Adobe Photoshop
® 7.0 software.
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